Pharmacy Times
MAY 16, 2025
Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.
Pharma Marketing Network
MAY 16, 2025
In today’s digital landscape, the integration of artificial intelligence (AI) into healthcare social media marketing is revolutionizing how organizations engage with patients and professionals. As AI technologies become more sophisticated, they offer unprecedented opportunities to personalize content, predict trends, and optimize campaigns. This evolution is not just a trend but a fundamental shift in how healthcare entities communicate and build trust with their audiences.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 16, 2025
In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation
Pharmacy Times
MAY 16, 2025
New data reveals that combining pertuzumab with trastuzumab significantly improves survival rates in HER2+ breast cancer patients, reducing death risk by 17%.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
MAY 16, 2025
Mergers that strategically focus on cultural integrationparticularly by empowering nursing teamsare more likely to achieve sustained success.
Pharmacy Times
MAY 16, 2025
Specialty pharmacists enhance CKD management through personalized care, medication adherence strategies, and collaboration with health care providers.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 16, 2025
A new study reveals that heart failure patients with implantable devices are more likely to receive the pneumococcal conjugate vaccine 13, impacting vaccination rates and mortality.
PharmaVoice
MAY 16, 2025
A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.
Pharmacy Times
MAY 16, 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Pharmaceutical Technology
MAY 16, 2025
The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was terminated in April.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 16, 2025
Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.
Fierce Healthcare
MAY 16, 2025
Executive and clinical leaders see revenue growth and AI adoption on the horizon, a joint report from NAACOS and Innovaccer reveals.
Pharmaceutical Technology
MAY 16, 2025
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.
European Pharmaceutical Review
MAY 16, 2025
Novo Nordisks current CEO, Lars Fruergaard Jrgensen, will step down. He remains in the position temporarily to support the transition to a new successor. The company cited this change to its executive leadership is due to the impact of recent market challenges, as well as the companys share price decline since mid-2024. This decision is in the best interest of the company and its shareholders, Novo Nordisk stated.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
MAY 16, 2025
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
pharmaphorum
MAY 16, 2025
Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle
Fierce Healthcare
MAY 16, 2025
A federal judge largely ruled against drugmakers on whether HHS had the authority to forbid their controversial overhauls to the subsidy program. The administrations final stance on whether it will ultimately choose to allow the rebates is still an open question.
European Pharmaceutical Review
MAY 16, 2025
Earlier this week, the UK Government published new plans for the reform of its immigration strategy. The policy paper outlined three key aims: grow the UKs domestic workforce, end reliance on overseas labour and boost growth of its domestic economy. 1 Addressing the UK government’s immigration whitepaper Although the proposals in the UK government’s immigration whitepaper could deliver benefit for a range of sectors, the science industry are calling for confidence and clarity from go
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Commerce
MAY 16, 2025
In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing.
pharmaphorum
MAY 16, 2025
At the recent AAPS National Biotech Conference 2025, pharmaphorum editor-in-chief Jonah Comstock caught up with Dr Dhaval Shah, a professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher who specialises in simulation and modelling for biologics.
Fierce Healthcare
MAY 16, 2025
The partners' vision has health systems conducting continuous nation-scale data analytics, with clinical takeaways being delivered to practitioners during care encounters.
PharmExec
MAY 16, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Fuld
MAY 16, 2025
This issue looks at some of the big shifts influencing business strategy right now. We explore BYDs global EV expansion, share reflections from the Strategic Consortium of Intelligence Professionals (SCIP) conference, IntelliCon, on how AI is shaping Competitive Intelligence, and update you on the next steps in our journey to net zero. Whats driving BYDs global EV strategy?
pharmaphorum
MAY 16, 2025
Incyte has broken new ground in immuno-oncology, getting FDA approval for its Zynyz drug as a treatment for anal cancer
Fierce Healthcare
MAY 16, 2025
Persivia, an AI-driven digital health solution, secured a $107 million investment, Plenful nabbed $50 million, Clarium picked up $27 million and Deerfield Management backed Ascertain's $10 million round in recent weeks.
PharmExec
MAY 16, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
pharmaphorum
MAY 16, 2025
Novo Nordisk's chief executive Lars Fruergaard Jrgensen is stepping down by "mutual agreement" with the company's board
Hospital Pharmacy Europe
MAY 16, 2025
A low-carbon version of a triple combination pressurised metred dose (pMDI) inhaler indicated for adults with moderate-to-severe chronic obstructive pulmonary disease (COPD) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), its manufacturer AstraZeneca has announced. The budesonide/glycopyrronium/formoterol fumarate inhaler (brand name Trixeo Aerosphere) currently uses the propellant hydrofluoroalkane-134a (HFA-134a), which is known for its high Global Warming
PharmExec
MAY 16, 2025
Tapping into the reader experience, our new comprehensive survey uncovers valuable input for navigating the changing tides facing pharma decision-makers.
STAT
MAY 16, 2025
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, for the most part, is rather modest. We plan to catch up on our reading, promenade with the official mascots, hang out at a porchfest, and hold still another listening party, where the rotation will likely include this , this , this , this and this.
Pharmaceutical Technology
MAY 16, 2025
US President Donald Trump has resurrected a drug pricing plan that equates to International Reference Pricing.
STAT
MAY 16, 2025
NEW ORLEANS — Last year, hundreds of people poured in to see Peter Marks, the Food and Drug Administration’s head of biologics, speak at the American Society of Gene and Cell Therapy conference. The regulator was seen by many advocates, researchers, and executives as an ally in their efforts to get rare disease treatments approved, sometimes despite limited or contradictory evidence.
Pharmaceutical Technology
MAY 16, 2025
The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.
Expert insights. Personalized for you.
Let's personalize your content